DLL4 loss-of-function heterozygous mutations cause Adams-Oliver syndrome von Aminkeng, F.

Volltext

GFI1B mutation causes autosomal dominant gray platelet syndrome von Aminkeng, F.

Volltext

PDGFRB mutation causes autosomal-dominant Penttinen syndrome von Aminkeng, F.

Volltext

HINT1 mutations define a novel disease entity - autosomal recessive axonal neuropathy with neuromyotonia von Aminkeng, F

Volltext

EIF2AK4 genetic mutations cause a recessive form of rare and deadly lung disease, pulmonary veno-occlusive disease von Aminkeng, F.

Volltext

WDR45 mutations define a novel disease entity-Static Encephalopathy of Childhood with Neurodegeneration in Adulthood von Aminkeng, F

Volltext

Using pharmacogenetics in real time to guide therapy: the warfarin example von Aminkeng, F.

Volltext

KCNT1 mutations in ADNFLE and MMPSI: a new driver in the etiology and pathophysiology of early-onset epileptic syndromes von Aminkeng, F

Volltext

Mutations in ATP1A3 cause alternating hemiplegia of childhood von Aminkeng, F

Volltext

The emerging era of pharmacogenomics: current successes, future potential, and challenges von Lee, J.W., Aminkeng, F., Bhavsar, A.P., Shaw, K., Carleton, B.C., Hayden, M.R., Ross, C.J.D.

Volltext

Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent von Aminkeng, F, Ross, C J D, Rassekh, S R, Brunham, L R, Sistonen, J, Dube, M-P, Ibrahim, M, Nyambo, T B, Omar, S A, Froment, A, Bodo, J-M, Tishkoff, S, Carleton, B C, Hayden, M R

Volltext

Pharmacogenomic diversity in Singaporean populations and Europeans von Brunham, L R, Chan, S L, Li, R, Aminkeng, F, Liu, X, Saw, W Y, Ong, R T H, Pillai, E N, Carleton, B C, Toh, D, Tan, S H, Koo, S H, Lee, E J D, Chia, K S, Ross, C J D, Hayden, M R, Sung, C, Teo, Y Y

Volltext

OP13 Association entre le polymorphisme rs7903146(C/T) du gène TCF7L2 et l'obésité dans une population Camerounaise von Metsadjio, A. Nguimmo, Sobngwi, E, Sontsa, O. Donfack, Dongwi, E.N, Mato, E.P. Mofo, Fokeng, M. Guewo, Pokam, P. Fosso, Djahmeni, E, Tiedeu, B. Atogho, Evehe, M.S, Djokam-Dadjeu, R, Aminkeng, F, Mbacham, W.F, Mbanya, J.C

Volltext

OP12 Association between the rs12255372 (G/T) polymorphism of the transcription factor 7 like-2 gene and type 2 diabetes in a Cameroonian population von Nanfa, D, Sobngwi, E, Sontsa, O. Donfack, Mato, E.P. Mofo, Fokeng, M. Guewo, Metsadjio, A. Nguimmo, Ndonwi, E.N, Pokam, P. Fosso, Djahmeni, E, Tiedeu, B. Atogho, Evehe, M.S, Djokam-Dadjeu, R, Aminkeng, F, Mbacham, W.F, Mbanya, J.C

Volltext

P2 Association of TCF7L2 with Type 2 diabetes in a Cameroonian population von Fokeng, M. Guewo, Sobngwi, E, Sontsa, O. Donfack, Ndonwi, E.N, Mato, E.P. Mofo, Pokam, P. Fosso, Djahmeni, E, Tiedeu, B. Atogho, Evehe, M.S, Djokam-Dadjeu, R, Aminkeng, F, Mbacham, W.F, Mbanya, J.C

Volltext

P17 No Association between Pro12Ala polymorphism in Peroxisome Proliferator Activated Receptor Gamma 2 gene and type 2 diabetes in a Cameroonian population von Mato, E.P. Mofo, Sobngwi, E, Sontsa, O. Donfack, Ndonwi, E.N, Fokeng, M. Guewo, Pokam, P. Fosso, Djahmeni, E, Tiedeu, B. Atogho, Evehe, M.S, Djokam-Dadjeu, R, Aminkeng, F, Mbacham, W.F, Mbanya, J.C

Volltext

P3 Genetic association of the transcription factor 7-like 2 (TCF7L2) gene with obesity in Cameroon von Ndonwi, E.N, Sobngwi, E, Sontsa, O. Donfack, Mato, E.P. Mofo, Fokeng, M. Guewo, Pokam, P. Fosso, Djahmeni, E, Tiedeu, B. Atogho, Evehe, M.S, Djokam-Dadjeu, R, Aminkeng, F, Mbacham, W.F, Mbanya, J.C

Volltext

P2.11A.11 Impact of Proton Pump Inhibitor Use on Faecal Microbiome in Patients with NSCLC Treated with Immune Checkpoint Inhibitor von Huang, Y., Lee, J., Sim, C.K., Zhao, J.J., Sooi, K., Wong, A., Tay, S.H., Soon, Y.Y., Aminkeng, F., Goh, B.C., Tan, D.S., Soo, R.A.

Volltext

EP08.01-101 Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLC von Huang, Y., Zhao, J.J., Soon, Y.Y., Kee, A., Tay, S.H., Aminkeng, F., Ang, Y., Wong, A., Goh, B.C., Soo, R.

Volltext

P75.10 Risk Factors for Immune-Related Adverse Events from Anti-PD-1/PD-L1 Treatment in an Asian Cohort of NSCLC Patients von Huang, Y., Soon, Y.Y., Aminkeng, F., Tay, S.H., Ang, Y., Goh, B.C., Wong, A., Soo, R.A.

Volltext